Transforming properties of <scp>MET</scp> receptor exon 14 skipping can be recapitulated by loss of the <scp>CBL</scp> ubiquitin ligase binding site
Marie Fernandes(Centre National de la Recherche Scientifique), David Tulasne(Centre National de la Recherche Scientifique)
Cited by 18
Related Papers
Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers
|JNCI Journal of the National Cancer Institute|2016|121
Thirty Years of Research on Met Receptor to Move a Biomarker from Bench to Bedside
|Cancer Research|2014|68